Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer

R.V. Lord, J. Brabender, D. Gandara, V. Alberola, C. Camps, M. Domine, F. Cardenal, J.M. Sánchez, P.H. Gumerlock, M. Tarón, J.J. Sanchez, K.D. Danenberg, P.V. Danenberg, R. Rosell

Research output: Contribution to journalArticleResearch

624 Citations (Scopus)
Original languageEnglish
Pages (from-to)2286-2291
JournalClin. Cancer Res.
Volume8
Issue number7
Publication statusPublished - 1 Jan 2002

Cite this

Lord, R. V., Brabender, J., Gandara, D., Alberola, V., Camps, C., Domine, M., Cardenal, F., Sánchez, J. M., Gumerlock, P. H., Tarón, M., Sanchez, J. J., Danenberg, K. D., Danenberg, P. V., & Rosell, R. (2002). Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Clin. Cancer Res., 8(7), 2286-2291.